# buprenorphine hydrochloride

NDC: 0121-1019
Generic name: buprenorphine hydrochloride
Labeler / Manufacturer: PAI Holdings, LLC dba Pharmaceutical Associates, Inc. and dba PAI Pharma
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET
Routes: SUBLINGUAL
Marketing started: 20231012

FDA application: ANDA090622

## Active ingredients

- BUPRENORPHINE HYDROCHLORIDE: 2 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0121-1019"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0121-1019
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=442831cf-9636-433a-9a12-e9a8cd31f72a